These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38669381)
1. Identification of prognostic m6A modification patterns and score system in melanoma patients. Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381 [TBL] [Abstract][Full Text] [Related]
2. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. m Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750 [TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer. Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164 [TBL] [Abstract][Full Text] [Related]
6. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X Front Immunol; 2022; 13():888650. PubMed ID: 35572541 [TBL] [Abstract][Full Text] [Related]
7. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J Front Genet; 2021; 12():752025. PubMed ID: 35046996 [No Abstract] [Full Text] [Related]
8. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G Front Immunol; 2021; 12():735170. PubMed ID: 34531875 [TBL] [Abstract][Full Text] [Related]
9. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Huang X; Qiu Z; Li L; Chen B; Huang P Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607 [TBL] [Abstract][Full Text] [Related]
10. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer. Cai L; Liu T; Hua H; Jiang X; Qian L BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752 [TBL] [Abstract][Full Text] [Related]
12. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia. Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q Front Immunol; 2021; 12():789914. PubMed ID: 34887874 [TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma. Wang G; Zeng D; Sweren E; Miao Y; Chen R; Chen J; Wang J; Liao W; Hu Z; Kang S; Garza LA J Invest Dermatol; 2023 Aug; 143(8):1579-1590.e5. PubMed ID: 36842525 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer. Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726 [No Abstract] [Full Text] [Related]
15. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma. Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694 [TBL] [Abstract][Full Text] [Related]
16. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Quan Y; Zhang X; Ping H Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837 [TBL] [Abstract][Full Text] [Related]
17. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma. Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX Front Immunol; 2021; 12():765723. PubMed ID: 35003079 [TBL] [Abstract][Full Text] [Related]
18. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment. Liu F; Yu X; He G J Oncol; 2021; 2021():9987376. PubMed ID: 34745261 [TBL] [Abstract][Full Text] [Related]
19. Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration. Yue Q; Zhang Y; Wang F; Cao F; Bai J; Duan X J Immunol Res; 2022; 2022():8766735. PubMed ID: 35692505 [TBL] [Abstract][Full Text] [Related]
20. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma. Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]